Loading...
    Loading...
    LEADERBOARD
labroots
Login here
Register Free
  • LOGIN
  • REGISTER FREE
  • Home
  • Virtual Events
      • Upcoming
      • On-Demand
      • Companies
      • Posters
      • Categories
      See More
      See More
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Webinars
      • Upcoming
      • On-Demand
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Trending News
      • Most Recent
      • What's Hot
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Drug Discovery & Development
      • Plants & Animals
      • Cannabis Sciences
      • Earth & The Environment
      • Space & Astronomy
      • Chemistry & Physics
      • Technology
  • Multimedia
      • Sponsored Content
      • eBooks
      • Podcasts
      • Infographics
      See More
      See More
      See More
      See More
  • Products
      • Categories
      • Companies
      • New
      • Popular
      Antibodies
      Immunity, Immunoassay, Immunotherapy
      Assay Kits
      Detection, Quantification
      Biomolecules
      Proteins
      Cell Biology
      Cell function
      Cell-Based Assays
      Cell viability
      Cell/Tissue Culture
      Cell lines, Cell growth, Cell differentiation
      Chemicals and Reagents
      Reagent kits, Laboratory chemicals
      Drug Discovery and Development
      Target identification, High-throughput screening
      Flow Cytometry
      Immunophenotyping, Cell cycle analysis
      Genomics
      Genome sequencing, Transcriptomics
      Imaging (Bio-Imaging / Microscopy)
      Fluorescence imaging
      Lab Automation
      High-throughput screening, Robotics, Liquid handling systems
      Lab Equipment
      Centrifuges, Incubators, Homogenizers, Sonicators
      Life Sciences
      Biological research, Biotechnology
      Molecular Biology
      DNA replication, Gene expression, PCR
      Next Gen Sequencing
      DNA sequencing, High-throughput sequencing, NGS platforms, RNA sequencing, miRNA sequencing, Accessory Products
      Quality Control and Validation
      QC standards, Quality assurance
      Single Cell Analysis
      Transcriptomics
      Technology
      Biotechnology, Instrumentation, Data analysis
      See More
      See More
      See More
  • Companies
      • See More
    • Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        See More
        See More
        See More
        Gift Card $25
        Gift Card $50
        Gift Card $75
        Gift Card $100
        See More
        Labroots Store Gift Card Balance
        $0.00
        Balance
        Gift Card Number:

        No gift card matches the entered value.

    • Continuing Education
    • More
      • Virtual Events
        • All Virtual Events
        • Upcoming
        • On-Demand
        • Posters
        • Companies
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Webinars
        • All Webinars
        • Upcoming
        • On-Demand
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Trending News
        • Most Recent
        • What's Hot
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Drug Discovery & Development
        • Plants & Animals
        • Cannabis Sciences
        • Earth & The Environment
        • Space & Astronomy
        • Chemistry & Physics
        • Technology
        Multimedia
        • Sponsored Content
        • eBooks
        • Podcasts
        • Infographics
        Companies
        Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        Continuing Education
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Blog
        • Scholarships
        • RSS
        • Contact Us
        • Continuing Education
        • Leaderboard
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Support
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Media Partnerships
        • Blog
        • Scholarships
        • Continuing Education
        • Leaderboard
        • Contact Us
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Request Demo
        Interested in Advertising
        with Labroots?
        Have questions? Visit our Support pages
    Login here
    Register Free
    Follow

    Cancer Treatment

    Cancer Treatment: are treatments that may include surgery, chemotherapy, and radiation therapy. If your cancer is particularly sensitive to radiation therapy or chemotherapy, you may receive one of those therapies as your primary treatment. Adjuvant treatment.

    Webinars

    • OCT 17, 2013 | 11:00 AM
      C.E. CREDITS
      The Need for Critical Reassessment of Current Strategies for Cancer Therapeutics.
      The Need for Critical Reassessment of Current Strategies for Cancer...
      Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
      Speaker: George Poste, DVM, DSc, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      42
      OCT 17, 2013 | 10:00 AM
      C.E. CREDITS
      The Molecular Mechanisms of Castration-Resistant Prostate Cancer
      The Molecular Mechanisms of Castration-Resistant Prostate Cancer
      Prostate cancer epithelial cells depend on androgens for their survival. Because of this dependence, androgen deprivation therapy is the major treatment of advanced prostate cancer. Such ther...
      Speaker: Donald Tindall, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      40
      OCT 17, 2013 | 9:00 AM
      C.E. CREDITS
      Subtyping Circulating Tumor Cells in Breast Cancer for Personalized Therapeutics
      Subtyping Circulating Tumor Cells in Breast Cancer for Personalized...
      Cancer metastases develop when tumor cells known as circulating tumor cells (CTCs) are shed from a tumor, circulate through the blood stream and colonize a distant tissue. The number of CTCs...
      Speaker: Lori M. Millner, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      86
      OCT 17, 2013 | 8:00 AM
      Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
      Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
      Many drugs currently used for anti-cancer therapy demonstrate significant inter-individual variability that cannot be normalized using body weight or body surface area. There is an increasing...
      Speaker: William Clarke, PhD, MBA, DABCC
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      264
      OCT 17, 2013 | 7:00 AM
      C.E. CREDITS
      Monitoring for Chemotherapy Toxicity and Cardiac Troponin
      Monitoring for Chemotherapy Toxicity and Cardiac Troponin
      Recent data have confirmed the ability of cardiac troponin (cTn) measurements to identify those who are developing cardiotoxicity in response to potentially cardiotoxic chemotherapeutic agen...
      Speaker: Allan Jaffe, M.D.
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      32
      OCT 17, 2013 | 6:00 AM
      A Bioinformatics Approach to Clinical Sequencing
      A Bioinformatics Approach to Clinical Sequencing
      The widespread adoption of precision medicine in oncology requires: a compendium of therapies targeting the genetic vulnerabilities of cancer; the diagnostic tools capable of generating a pr...
      Speaker: Dan Rhodes, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 3:00 PM
      C.E. CREDITS
      Recent Developments in the treatment of Melanoma
      Recent Developments in the treatment of Melanoma
      While Melanoma is very curable and treatable when detected early, late stage melanoma has had a very poor outcome. In 2013, it is estimated that over 80,000 patients in the US will develop me...
      Speaker: Adil Daud, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      36
      OCT 16, 2013 | 2:00 PM
      C.E. CREDITS
      Novel therapies for ALK mutated cancers
      Novel therapies for ALK mutated cancers
      Non Small Cell Lung Cancer (NSCLC) is one of the most significant causes of cancer-related mortality worldwide. In about 6-7% of NSCLC, rearrangements involving the Anaplastic Lymphoma Kinase...
      Speaker: Roberto Chiarle, MD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      32
      OCT 16, 2013 | 2:00 PM
      C.E. CREDITS
      PSA Screening and Early Detection for Prostate Cancer 2013: Controversy and Opportunity
      PSA Screening and Early Detection for Prostate Cancer 2013: Controversy...
      While the Prostate Specific Antigen (PSA) blood test has been available since 1986 and FDA-approved for the early detection of prostate cancer since the early 1990s, 2012 marked a critical in...
      Speaker: Judd W Moul, MD, FACS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
      Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
      Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
      Speaker: Kristin Landis-Piwowar, PhD, MLS
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      129
      OCT 16, 2013 | 1:00 PM
      C.E. CREDITS
      Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
      Resistance to AR Signaling Inhibitors in Castration Resistant...
      While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
      Speaker: Elahe A Mostaghel, MD, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      80
      OCT 16, 2013 | 12:00 PM
      C.E. CREDITS
      New therapeutic strategies and new modes of drug resistance: From the bench to bedside and back again with the oncogene eIF4E
      New therapeutic strategies and new modes of drug resistance: From...
      The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well a...
      Speaker: Katherine LB Borden, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      60
      OCT 16, 2013 | 10:00 AM
      C.E. CREDITS
      Keynote: Is Personalized (Molecularly-Based) Medicine our Best Hope to Finally Defeat Cancer?
      Keynote: Is Personalized (Molecularly-Based) Medicine our Best...
      The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...
      Speaker: Anna Barker, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      37
      OCT 16, 2013 | 9:00 AM
      C.E. CREDITS
      Keynote: Breast Cancer Genomics and Genetics
      Keynote: Breast Cancer Genomics and Genetics
      It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
      Speaker: Charles M. Perou, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      132
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
      Prognostic, predictive, and surrogate biomarkers in men with castration...
      With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
      Speaker: Andrew Armstrong, MD ScM FACP
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      96
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Novel strategies for the targeted delivery of anti-cancer drugs in bladder cancer  CME and CE Credits Available
      Novel strategies for the targeted delivery of anti-cancer drugs...
      The adjuvant therapy of choice for superficial bladder cancer is the intravesical instillation of live Mycobacterium bovis Bacillus Calmette-Guerin (BCG). In spite of the fact that this thera...
      Speaker: R. Claudio Aguilar, PhD
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      34
      AUG 22, 2013 | 5:00 PM
      C.E. CREDITS
      Genomic Profiles of Asian Endemic Cancers
      Genomic Profiles of Asian Endemic Cancers
      Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...
      Speaker: Prof. Patrick Tan, MD, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      38
      AUG 22, 2013 | 1:00 PM
      Embracing the Complexity of Cancer: Seeing the Forest and the Trees
      Embracing the Complexity of Cancer: Seeing the Forest and the...
      Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
      Speaker: Kenneth Buetow, PhD, FACMI
      Presented at: Genetics and Genomics Virtual Event Series 2013
      92
      AUG 22, 2013 | 7:00 AM
      Soluble 14-3-3? -  A Personalised Rheumatoid Arthritis Patient Management Strategy
      Soluble 14-3-3? - A Personalised Rheumatoid Arthritis Patient...
      Rheumatoid Arthritis (RA) is a heterogenous disease that affects 1.5% of the population. Similar to cancer, early detection coupled with an effective treatment strategy can significantly impr...
      Speaker: Anthony Marotta, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      52
      AUG 21, 2013 | 1:00 PM
      Bioinformatics and Quantitative Genomics in Cervical Cancer Screening
      Bioinformatics and Quantitative Genomics in Cervical Cancer Screening
      Cervical cancer screening has evolved significantly since the PAP smear was introduced in 1949. In particular, the association with human papillomavirus (HPV) infection and the mechanism of H...
      Speaker: Bruce K Patterson, MD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      59 1
      AUG 21, 2013 | 10:00 AM
      C.E. CREDITS
      Genomic Approaches to Discover Biomarkers of Drug Response in Cancer
      Genomic Approaches to Discover Biomarkers of Drug Response in...
      Massively parallel sequencing technology has proven to enable the identification of driver genetic alterations in patients' tumors that may be suppressed by targeted therapies. Through retros...
      Speaker: Michael F Berger, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      117
      AUG 21, 2013 | 10:00 AM
      C.E. CREDITS
      Integration of Genomics into Medical Practice: Educational Challenges
      Integration of Genomics into Medical Practice: Educational Challenges
      Medical applications of genetics and genomics have been advancing dramatically since completion of the sequencing of the human genome. The cost of DNA sequencing has plummeted, leading to the...
      Speaker: Bruce R. Korf, MD, PhD
      Presented at: Genetics and Genomics Virtual Event Series 2013
      80
      MAR 01, 2013 | 8:00 AM
      Diamond-Based Nanomedicine for Enhanced Cancer Treatment and Imaging
      Diamond-Based Nanomedicine for Enhanced Cancer Treatment and Imaging
      Abstract: Understand unique attributes of diamond-based nanoparticles and why it is used for imaging for cancer and drug delivery Understand in-vitro and in-vivo applications of diamond...
      Speaker: Dean Ho
      Presented at: Beckman Coulter Life Sciences Virtual Trade Show
      Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
      0
      SEP 13, 2012 | 10:00 AM
      C.E. CREDITS
      Targeting the oncogene eIF4E at the bench and in the clinic
      Targeting the oncogene eIF4E at the bench and in the clinic
       The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well ...
      Speaker: Katherine LB Borden, PhD
      Sponsored By: Thermo Fisher Scientific, Thermo Fisher Scientific
      35
    OCT 17, 2013 | 11:00 AM
    C.E. CREDITS
    The Need for Critical Reassessment of Current Strategies for Cancer Therapeutics.
    The Need for Critical Reassessment of Current Strategies for Cancer...
    Curative therapy for metastatic disease in solid malignancies remains frustratingly elusive due to the long recognized problem of tumor cell heterogeneity and emergence of treatment resistant...
    Speaker: George Poste, DVM, DSc, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    42
    OCT 17, 2013 | 10:00 AM
    C.E. CREDITS
    The Molecular Mechanisms of Castration-Resistant Prostate Cancer
    The Molecular Mechanisms of Castration-Resistant Prostate Cancer
    Prostate cancer epithelial cells depend on androgens for their survival. Because of this dependence, androgen deprivation therapy is the major treatment of advanced prostate cancer. Such ther...
    Speaker: Donald Tindall, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    40
    OCT 17, 2013 | 9:00 AM
    C.E. CREDITS
    Subtyping Circulating Tumor Cells in Breast Cancer for Personalized Therapeutics
    Subtyping Circulating Tumor Cells in Breast Cancer for Personalized...
    Cancer metastases develop when tumor cells known as circulating tumor cells (CTCs) are shed from a tumor, circulate through the blood stream and colonize a distant tissue. The number of CTCs...
    Speaker: Lori M. Millner, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    86
    OCT 17, 2013 | 8:00 AM
    Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
    Therapeutic Drug Monitoring (TDM) in Cancer Chemotherapy
    Many drugs currently used for anti-cancer therapy demonstrate significant inter-individual variability that cannot be normalized using body weight or body surface area. There is an increasing...
    Speaker: William Clarke, PhD, MBA, DABCC
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    264
    OCT 17, 2013 | 7:00 AM
    C.E. CREDITS
    Monitoring for Chemotherapy Toxicity and Cardiac Troponin
    Monitoring for Chemotherapy Toxicity and Cardiac Troponin
    Recent data have confirmed the ability of cardiac troponin (cTn) measurements to identify those who are developing cardiotoxicity in response to potentially cardiotoxic chemotherapeutic agen...
    Speaker: Allan Jaffe, M.D.
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    32
     
     
  • OCT 17, 2013 | 6:00 AM
    A Bioinformatics Approach to Clinical Sequencing
    A Bioinformatics Approach to Clinical Sequencing
    The widespread adoption of precision medicine in oncology requires: a compendium of therapies targeting the genetic vulnerabilities of cancer; the diagnostic tools capable of generating a pr...
    Speaker: Dan Rhodes, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 3:00 PM
    C.E. CREDITS
    Recent Developments in the treatment of Melanoma
    Recent Developments in the treatment of Melanoma
    While Melanoma is very curable and treatable when detected early, late stage melanoma has had a very poor outcome. In 2013, it is estimated that over 80,000 patients in the US will develop me...
    Speaker: Adil Daud, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    36
    OCT 16, 2013 | 2:00 PM
    C.E. CREDITS
    Novel therapies for ALK mutated cancers
    Novel therapies for ALK mutated cancers
    Non Small Cell Lung Cancer (NSCLC) is one of the most significant causes of cancer-related mortality worldwide. In about 6-7% of NSCLC, rearrangements involving the Anaplastic Lymphoma Kinase...
    Speaker: Roberto Chiarle, MD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    32
    OCT 16, 2013 | 2:00 PM
    C.E. CREDITS
    PSA Screening and Early Detection for Prostate Cancer 2013: Controversy and Opportunity
    PSA Screening and Early Detection for Prostate Cancer 2013: Controversy...
    While the Prostate Specific Antigen (PSA) blood test has been available since 1986 and FDA-approved for the early detection of prostate cancer since the early 1990s, 2012 marked a critical in...
    Speaker: Judd W Moul, MD, FACS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of Cancer
    Molecular Diagnostics in Detection, Diagnosis, and Prognosis of...
    Cancer cells have historically been classified by microscopic analysis of blood smears and tissue sections. Current technologies use molecular techniques to categorize and classify tumor cell...
    Speaker: Kristin Landis-Piwowar, PhD, MLS
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    129
     
     
  • OCT 16, 2013 | 1:00 PM
    C.E. CREDITS
    Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer
    Resistance to AR Signaling Inhibitors in Castration Resistant...
    While androgen deprivation therapy (ADT) remains the primary treatment modality for patients with metastatic prostate cancer (PCa), treatment is uniformly marked by progression to castration-...
    Speaker: Elahe A Mostaghel, MD, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    80
    OCT 16, 2013 | 12:00 PM
    C.E. CREDITS
    New therapeutic strategies and new modes of drug resistance: From the bench to bedside and back again with the oncogene eIF4E
    New therapeutic strategies and new modes of drug resistance: From...
    The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well a...
    Speaker: Katherine LB Borden, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    60
    OCT 16, 2013 | 10:00 AM
    C.E. CREDITS
    Keynote: Is Personalized (Molecularly-Based) Medicine our Best Hope to Finally Defeat Cancer?
    Keynote: Is Personalized (Molecularly-Based) Medicine our Best...
    The current paradigm of detecting established cancer (often too late) and treating routinely with cytotoxic drugs is beginning to change. Advanced technologies such as whole genome sequencin...
    Speaker: Anna Barker, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    37
    OCT 16, 2013 | 9:00 AM
    C.E. CREDITS
    Keynote: Breast Cancer Genomics and Genetics
    Keynote: Breast Cancer Genomics and Genetics
    It is now appreciated that breast cancer is not a single disease, but instead is a spectrum of tumor subtypes with distinct cellular origins, somatic changes and somewhat predictable clinical...
    Speaker: Charles M. Perou, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    132
    OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
    Prognostic, predictive, and surrogate biomarkers in men with castration...
    With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
    Speaker: Andrew Armstrong, MD ScM FACP
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    96
     
     
  • OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Novel strategies for the targeted delivery of anti-cancer drugs in bladder cancer  CME and CE Credits Available
    Novel strategies for the targeted delivery of anti-cancer drugs...
    The adjuvant therapy of choice for superficial bladder cancer is the intravesical instillation of live Mycobacterium bovis Bacillus Calmette-Guerin (BCG). In spite of the fact that this thera...
    Speaker: R. Claudio Aguilar, PhD
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    34
    AUG 22, 2013 | 5:00 PM
    C.E. CREDITS
    Genomic Profiles of Asian Endemic Cancers
    Genomic Profiles of Asian Endemic Cancers
    Malignancies caused by so-called Type I chemical and biological carcinogens provide important opportunities studying early events in cancer development, providing essential information for de...
    Speaker: Prof. Patrick Tan, MD, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    38
    AUG 22, 2013 | 1:00 PM
    Embracing the Complexity of Cancer: Seeing the Forest and the Trees
    Embracing the Complexity of Cancer: Seeing the Forest and the...
    Personalized medicine is transforming biomedical research and healthcare service delivery. Disease definition, diagnosis, treatment, and prevention are being fundamentally altered by the capa...
    Speaker: Kenneth Buetow, PhD, FACMI
    Presented at: Genetics and Genomics Virtual Event Series 2013
    92
    AUG 22, 2013 | 7:00 AM
    Soluble 14-3-3? -  A Personalised Rheumatoid Arthritis Patient Management Strategy
    Soluble 14-3-3? - A Personalised Rheumatoid Arthritis Patient...
    Rheumatoid Arthritis (RA) is a heterogenous disease that affects 1.5% of the population. Similar to cancer, early detection coupled with an effective treatment strategy can significantly impr...
    Speaker: Anthony Marotta, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    52
    AUG 21, 2013 | 1:00 PM
    Bioinformatics and Quantitative Genomics in Cervical Cancer Screening
    Bioinformatics and Quantitative Genomics in Cervical Cancer Screening
    Cervical cancer screening has evolved significantly since the PAP smear was introduced in 1949. In particular, the association with human papillomavirus (HPV) infection and the mechanism of H...
    Speaker: Bruce K Patterson, MD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    59 1
     
     
  • AUG 21, 2013 | 10:00 AM
    C.E. CREDITS
    Genomic Approaches to Discover Biomarkers of Drug Response in Cancer
    Genomic Approaches to Discover Biomarkers of Drug Response in...
    Massively parallel sequencing technology has proven to enable the identification of driver genetic alterations in patients' tumors that may be suppressed by targeted therapies. Through retros...
    Speaker: Michael F Berger, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    117
    AUG 21, 2013 | 10:00 AM
    C.E. CREDITS
    Integration of Genomics into Medical Practice: Educational Challenges
    Integration of Genomics into Medical Practice: Educational Challenges
    Medical applications of genetics and genomics have been advancing dramatically since completion of the sequencing of the human genome. The cost of DNA sequencing has plummeted, leading to the...
    Speaker: Bruce R. Korf, MD, PhD
    Presented at: Genetics and Genomics Virtual Event Series 2013
    80
    MAR 01, 2013 | 8:00 AM
    Diamond-Based Nanomedicine for Enhanced Cancer Treatment and Imaging
    Diamond-Based Nanomedicine for Enhanced Cancer Treatment and Imaging
    Abstract: Understand unique attributes of diamond-based nanoparticles and why it is used for imaging for cancer and drug delivery Understand in-vitro and in-vivo applications of diamond...
    Speaker: Dean Ho
    Presented at: Beckman Coulter Life Sciences Virtual Trade Show
    Sponsored By: Beckman Coulter Life Sciences, Beckman Coulter Life Sciences
    0
    SEP 13, 2012 | 10:00 AM
    C.E. CREDITS
    Targeting the oncogene eIF4E at the bench and in the clinic
    Targeting the oncogene eIF4E at the bench and in the clinic
     The eukaryotic translation initiation factor eIF4E is a potent oncogene estimated to be elevated in about 30% of human cancers including cancers of the breast, prostate, lung, colon as well ...
    Speaker: Katherine LB Borden, PhD
    Sponsored By: Thermo Fisher Scientific, Thermo Fisher Scientific
    35
    Related Tags
    See more See less
    Let's Talk Science. Let's Talk Medicine.

    The leading scientific social networking website and producer of educational virtual events and webinars.

    About Us The Team Contact Us Careers Media Kit Virtual Events Posters Multimedia Blog Press Room Science Store Gift Card Balance
    Continuing Education Scholarships Leaderboard Order Policy Shipping Policy Privacy Policy Terms and Conditions User Agreement User Data Request Copyrights Support Chati
    © 2008-2025 Labroots Inc.
    Opens in a new window Opens an external site Opens an external site in a new window
    Modal title